首页> 外文期刊>Diabetes >Oxidative Stress As A Major Culprit In Kidney Disease In Diabetes
【24h】

Oxidative Stress As A Major Culprit In Kidney Disease In Diabetes

机译:氧化应激是糖尿病肾脏疾病的主要病因

获取原文
获取原文并翻译 | 示例
       

摘要

It is postulated that localized tissue oxidative stress is a key component in the development of diabetic nephropa-thy. There remains controversy, however, as to whether this is an early link between hyperglycemia and renal disease or develops as a consequence of other primary pathogenic mechanisms. In the kidney, a number of pathways that generate reactive oxygen species (ROS) such as glycolysis, specific defects in the polyol pathway, uncoupling of nitric oxide synthase, xanthine oxidase, NAD(P)H oxidase, and advanced glycation have been identified as potentially major contributors to the pathogenesis of diabetic kidney disease. In addition, a unifying hypothesis has been proposed whereby mitochondrial production of ROS in response to chronic hyperglycemia may be the key initiator for each of these pathogenic pathways. This postulate emphasizes the importance of mitochondrial dysfunction in the progression and development of diabetes complications including nephropathy. A mystery remains, however, as to why antioxidants per se have demonstrated minimal renoprotection in humans despite positive preclin-ical research findings. It is likely that the utility of current study approaches, such as vitamin use, may not be the ideal antioxidant strategy in human diabetic nephropathy. There is now an increasing body of data to suggest that strategies involving a more targeted antioxidant approach, using agents that penetrate specific cellular compartments, may be the elusive additive therapy required to further optimize renoprotection in diabetes.
机译:据推测,局部组织氧化应激是糖尿病性肾病的发展的关键组成部分。然而,关于这是高血糖与肾脏疾病之间的早期联系还是由于其他主要致病机制的发展,仍存在争议。在肾脏中,已识别出许多产生活性氧(ROS)的途径,例如糖酵解,多元醇途径中的特定缺陷,一氧化氮合酶,黄嘌呤氧化酶,NAD(P)H氧化酶的解偶联和高级糖基化。可能是糖尿病肾病发病机理的主要贡献者。另外,已经提出了统一的假设,其中响应于慢性高血糖的线粒体ROS的产生可能是这些致病途径中每一个的关键引发剂。该假设强调线粒体功能障碍在糖尿病并发症(包括肾病)的进展和发展中的重要性。然而,关于为什么抗氧化剂本身在临床前研究中取得积极成果的原因,却仍然证明对人类的肾脏保护作用极低,仍是一个谜。当前研究方法的实用性(例如使用维生素)可能不是人类糖尿病肾病中理想的抗氧化剂策略。现在,越来越多的数据表明,涉及一种更具针对性的抗氧化剂方法的策略(使用可穿透特定细胞区室的药物)可能是进一步优化糖尿病的肾脏保护所需要的难以捉摸的附加疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号